IGC PHARMA INC. DL -,01 earnings per share and revenue

IGS1 earnings per share for the last quarter are -0.08 EUR whereas the estimation was -0.04 EUR which accounts for -125.00% surprise. Company revenue for the same period amounts to 184.83 k EUR despite the estimated figure of 362.40 k EUR. Estimated earnings per share for the next quarter are -0.04 EUR, and revenue is expected to reach 178.87 k EUR. Also watch annual changes over time to get a bigger picture of IGS1 earnings per share and revenue dynamics.